Correlates of human papillomavirus vaccine series completion among young adult female initiators

References

• Hariri S, Unger ER, Sternberg M, Dunne EF, Swan D, Patel S, Markowitz LE. Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006. J Infect Dis 2011; 204:566 - 73; http://dx.doi.org/10.1093/infdis/jir341; PMID: 21791659
   PubMed Web of Science ®Google Scholar
• Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S, Bruni L, Tortolero-Luna G, Kjaer SK, Muñoz N. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 2008; 26:Suppl 10 K1 - 16; http://dx.doi.org/10.1016/j.vaccine.2008.05.064; PMID: 18847553
   PubMed Web of Science ®Google Scholar
• Garland SM, Steben M, Sings HL, James M, Lu S, Railkar R, Barr E, Haupt RM, Joura EA. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. J Infect Dis 2009; 199:805 - 14; http://dx.doi.org/10.1086/597071; PMID: 19199546
   PubMed Web of Science ®Google Scholar
• Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER, Centers for Disease Control and Prevention (CDC), Advisory Committee on Immunization Practices (ACIP). Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007; 56:RR-2 1 - 24; PMID: 17380109
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC). FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010; 59:626 - 9; PMID: 20508593
   PubMedGoogle Scholar
• Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, Tang GW, Ferris DG, Steben M, Bryan J, et al, Females United to Unilaterally Reduce Endo/Ectocervical Disease (FUTURE) I Investigators. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007; 356:1928 - 43; http://dx.doi.org/10.1056/NEJMoa061760; PMID: 17494926
   PubMed Web of Science ®Google Scholar
• Paavonen J, Naud P, Salmerón J, Wheeler CM, Chow SN, Apter D, Kitchener H, Castellsague X, Teixeira JC, Skinner SR, et al, HPV PATRICIA Study Group. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009; 374:301 - 14; http://dx.doi.org/10.1016/S0140-6736(09)61248-4; PMID: 19586656
   PubMed Web of Science ®Google Scholar
• Laz TH, Rahman M, Berenson AB. Human papillomavirus vaccine uptake among 18- to 26-year-old women in the United States: National Health Interview Survey, 2010. Cancer 2013; 119:1386 - 92; http://dx.doi.org/10.1002/cncr.27894; PMID: 23508594
   PubMed Web of Science ®Google Scholar
• Dobson SR, McNeil S, Dionne M, Dawar M, Ogilvie G, Krajden M, Sauvageau C, Scheifele DW, Kollmann TR, Halperin SA, et al. Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial. JAMA 2013; 309:1793 - 802; http://dx.doi.org/10.1001/jama.2013.1625; PMID: 23632723
   PubMed Web of Science ®Google Scholar
• Rahman M. LAZ TH, Berenson AB. Geographic variation in human papillomavirus vaccination uptake among young adult women in the United States during 2008-2010. Vaccine. 2013 Nov 12;31(47):5495-9
   Google Scholar
• Jain N, Euler GL, Shefer A, Lu P, Yankey D, Markowitz L. Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007. Prev Med 2009; 48:426 - 31; http://dx.doi.org/10.1016/j.ypmed.2008.11.010; PMID: 19100762
   PubMed Web of Science ®Google Scholar
• Caskey R, Lindau ST, Alexander GC. Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey. J Adolesc Health 2009; 45:453 - 62; http://dx.doi.org/10.1016/j.jadohealth.2009.04.021; PMID: 19837351
   PubMed Web of Science ®Google Scholar
• Taylor LD, Hariri S, Sternberg M, Dunne EF, Markowitz LE. Human papillomavirus vaccine coverage in the United States, National Health and Nutrition Examination Survey, 2007-2008. Prev Med 2011; 52:398 - 400; http://dx.doi.org/10.1016/j.ypmed.2010.11.006; PMID: 21108962
   PubMed Web of Science ®Google Scholar
• Anhang Price R, Tiro JA, Saraiya M, Meissner H, Breen N. Use of human papillomavirus vaccines among young adult women in the United States: an analysis of the 2008 National Health Interview Survey. Cancer 2011; 117:5560 - 8; http://dx.doi.org/10.1002/cncr.26244; PMID: 21732336
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Vaccination coverage estimates from the National Health Interview Survey: United States, 2008. NCHS Health E-Stats 2009. Available from URL: http://www.cdc.gov/nchs/data/hestat/vaccine_coverage/vaccine_coverage.pdf [Accessed Jan 11, 2014]
   Google Scholar
• Williams WW, Lu PJ, Saraiya M, Yankey D, Dorell C, Rodriguez JL, Kepka D, Markowitz LE. Factors associated with human papillomavirus vaccination among young adult women in the United States. Vaccine 2013; 31:2937 - 46; http://dx.doi.org/10.1016/j.vaccine.2013.04.041; PMID: 23643629
   PubMed Web of Science ®Google Scholar
• Chou B, Krill LS, Horton BB, Barat CE, Trimble CL. Disparities in human papillomavirus vaccine completion among vaccine initiators. Obstet Gynecol 2011; 118:14 - 20; http://dx.doi.org/10.1097/AOG.0b013e318220ebf3; PMID: 21691158
   PubMed Web of Science ®Google Scholar
• Chao C, Velicer C, Slezak JM, Jacobsen SJ. Correlates for completion of 3-dose regimen of HPV vaccine in female members of a managed care organization. Mayo Clin Proc 2009; 84:864 - 70; http://dx.doi.org/10.4065/84.10.864; PMID: 19797775
   PubMed Web of Science ®Google Scholar
• Watson M, Saraiya M, Benard V, Coughlin SS, Flowers L, Cokkinides V, Schwenn M, Huang Y, Giuliano A. Burden of cervical cancer in the United States, 1998-2003. Cancer 2008; 113:Suppl 2855 - 64; http://dx.doi.org/10.1002/cncr.23756; PMID: 18980204
   PubMed Web of Science ®Google Scholar
• Mokdad AH. The Behavioral Risk Factors Surveillance System: past, present, and future. Annu Rev Public Health 2009; 30:43 - 54; http://dx.doi.org/10.1146/annurev.publhealth.031308.100226; PMID: 19705555
   PubMed Web of Science ®Google Scholar
• Census Bureau Regions and Divisions with State FIPS Codes”. US Census Bureau. http://www.census.gov/geo/www/us_regdiv.pdf. Accessed on Feb 24, 2013.
   Google Scholar